1. Home
  2. GOODO vs VCEL Comparison

GOODO vs VCEL Comparison

Compare GOODO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share

GOODO

Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share

N/A

Current Price

$17.85

Market Cap

0.0

Sector

Real Estate

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

N/A

Current Price

$58.57

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GOODO
VCEL
Founded
N/A
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.1B
IPO Year
2003
1996

Fundamental Metrics

Financial Performance
Metric
GOODO
VCEL
Price
$17.85
$58.57
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $65.43
AVG Volume (30 Days)
6.1K
★ 836.1K
Earning Date
N/A
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 60.00
EPS
0.08
★ 0.19
Revenue
$161,336,000.00
★ $276,259,000.00
Revenue This Year
N/A
$24.98
Revenue Next Year
N/A
$15.37
P/E Ratio
★ $223.13
$304.53
Revenue Growth
8.00
★ 16.45
52 Week Low
$17.49
$28.95
52 Week High
$22.20
$59.75

Technical Indicators

Market Signals
Indicator
GOODO
VCEL
Relative Strength Index (RSI) 43.18 75.73
Support Level $17.50 $31.94
Resistance Level $18.21 $59.75
Average True Range (ATR) 0.21 2.60
MACD 0.07 0.84
Stochastic Oscillator 46.25 94.19

Price Performance

Historical Comparison
GOODO
VCEL

About GOODO Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: